Clinical Trial Update: Accelerated Hypofractionated Radiotherapy in the Treatment of Malignant Pleural Mesothelioma [NA]

View source ↗

Summary

Clinical trial NCT03269227 assessing accelerated hypofractionated radiotherapy for malignant pleural mesothelioma is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Pleural Mesothelioma

Snippet

Sponsor: Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS | Conditions: Malignant Pleural Mesothelioma | NA | Status: ACTIVE_NOT_RECRUITING